The Company Reports Consolidated Earnings Results for the Full Year Ended April 30, 2018; Provides Earnings Guidance for the Half Year and Full Year of Fiscal Year Ending April 30, 2019
June 05, 2018 at 04:00 am EDT
Share
The company reported consolidated earnings results for the full year ended April 30, 2018. For the year, the company's net sales were ¥268,385 million against ¥248,110 million a year ago. Operating income was ¥19,622 million against ¥14,563 million a year ago. Ordinary income was ¥20,129 million against ¥15,080 million a year ago. Profit attributable to owners of parent was ¥10,567 million or ¥310.08 per share against ¥7,949 million or ¥250.71 per share a year ago. Return on equity was 13.5% against 14.0% a year ago. Income before income taxes was ¥17,852.591 million against ¥14,307.556 million a year ago. Net cash provided by operating activities was ¥21,656.606 million against ¥21,352.1361 million a year ago. Payments for purchases of property, plant and equipment was ¥2,415.960 million against ¥2,415.960 million a year ago. Payments for purchases of intangible fixed assets were ¥574.817 million against ¥1,032,219 million a year ago.
For the first half of fiscal year ending April 30, 2019, the company expects net sales to be ¥132,350 million, operating income to be ¥7,040 million, ordinary income to be ¥7,290 million and net income to be ¥3,740 million or ¥105.57 per share.
For the year ending April 30, 2019, the company expects net sales to be ¥272,870 million, operating income to be ¥17,500 million, ordinary income to be ¥18,000 million and net income to be ¥9,260 million or ¥261.38 per share.
Ain Holdings Inc, is a Japan-based company engaged in the operation of pharmacies and retail business. The Company has three business segments. The Pharmacy segment operates and franchises pharmacies, and provides consulting services related to opening pharmacies. Through its subsidiaries, this segment is also involved in the provision of consultation services for medical-related affairs and manpower dispatching of doctors and pharmacists, as well as the sale of generic drugs. The Retail segment operates cosmetics business and drugstores. The Others segment is engaged in the leasing of buildings and the sales of cosmetics.
The Company Reports Consolidated Earnings Results for the Full Year Ended April 30, 2018; Provides Earnings Guidance for the Half Year and Full Year of Fiscal Year Ending April 30, 2019